Wells Fargo
CALC icon

Wells Fargo’s CalciMedica CALC Stock Holding History

Wells Fargo’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Hold
2
– – ﹤0.01% 7065
2026
Q1 		$5 Hold
2
– – ﹤0.01% 7023
2025
Q4 		$66 Buy
+2
New +$39 ﹤0.01% 6476
2024
Q2 		– Sell
-11
Closed -$229 – 6964
2024
Q1 		$229 Buy
11
+8
+267% +$183 ﹤0.01% 6463
2023
Q4 		$46 Hold
3
– – ﹤0.01% 6949
2023
Q3 		$40 Hold
3
– – ﹤0.01% 6978
2023
Q2 		$56 Buy
+3
New +$66 ﹤0.01% 7030
2023
Q1 		– Sell
-2
Closed -$54 – 7678
2022
Q4 		$54 Buy
2
+1
+100% +$56 ﹤0.01% 6984
2022
Q3 		$0 Hold
1
– – ﹤0.01% 6701
2022
Q2 		$0 Hold
1
– – ﹤0.01% 6840
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7096
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7249
2021
Q3 		$0 Hold
1
– – ﹤0.01% 6991
2021
Q2 		$0 Sell
1
-28
-97% -$9.18K ﹤0.01% 6923
2021
Q1 		$11K Sell
29
-19
-40% -$28.4K ﹤0.01% 6306
2020
Q4 		$98K Buy
+48
New +$70.8K ﹤0.01% 5366

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's CALC Position: Q2 2026 in Review

Wells Fargo held its CalciMedica (CALC) position steady in Q2 2026 at 2 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #7065.

Wells Fargo first reported a position in CALC in Q4 2020 and has held it in 16 quarters since. The position peaked at $98K in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Wells Fargo held 2 shares of CalciMedica worth $10 as of Q2 2026.
  • Wells Fargo left its CalciMedica share count unchanged in Q2 2026.
  • CalciMedica made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #7065 holding.
  • Wells Fargo first reported a position in CalciMedica in Q4 2020 and has held it in 16 quarters since.
  • Wells Fargo's CalciMedica position peaked at $98K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.